These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 14993244)

  • 21. Type 2 diabetes mellitus is associated with differential effects on plasma cholesteryl ester transfer protein and phospholipid transfer protein activities and concentrations.
    Dullaart RP; De Vries R; Scheek L; Borggreve SE; Van Gent T; Dallinga-Thie GM; Ito M; Nagano M; Sluiter WJ; Hattori H; Van Tol A
    Scand J Clin Lab Invest; 2004; 64(3):205-15. PubMed ID: 15222630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low cholesteryl ester transfer protein and phospholipid transfer protein activities are the factors making tree shrew and beijing duck resistant to atherosclerosis.
    Liu HR; Wu G; Zhou B; Chen BS
    Lipids Health Dis; 2010 Oct; 9():114. PubMed ID: 20937151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. Physiological relevance in alcoholic patients.
    Lagrost L; Athias A; Herbeth B; Guyard-Dangremont V; Artur Y; Paille F; Gambert P; Lallemant C
    J Biol Chem; 1996 Aug; 271(32):19058-65. PubMed ID: 8702577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transgenic mice expressing human phospholipid transfer protein have increased HDL/non-HDL cholesterol ratio.
    Albers JJ; Tu AY; Paigen B; Chen H; Cheung MC; Marcovina SM
    Int J Clin Lab Res; 1996; 26(4):262-7. PubMed ID: 9007618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute and chronic effects of a 24-hour intravenous triglyceride emulsion challenge on plasma lecithin: cholesterol acyltransferase, phospholipid transfer protein, and cholesteryl ester transfer protein activities.
    Riemens SC; Van Tol A; Sluiter WJ; Dullaart RP
    J Lipid Res; 1999 Aug; 40(8):1459-66. PubMed ID: 10428982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma lipid transfer proteins: The role of PLTP and CETP in atherogenesis.
    Chowaniec Z; Skoczyńska A
    Adv Clin Exp Med; 2018 Mar; 27(3):429-436. PubMed ID: 29558025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postprandial variations in the cholesteryl ester transfer protein activity, phospholipid transfer protein activity and plasma cholesterol efflux capacity in normolipidemic men.
    Syeda F; Senault C; Delplanque B; Le Roy B; Thaminy A; Gripois D; Blouquit MF; Ruelland A; Mendy F; Lutton C
    Nutr Metab Cardiovasc Dis; 2003 Feb; 13(1):28-36. PubMed ID: 12772435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variations in serum cholesteryl ester transfer and phospholipid transfer activities in healthy women and men consuming diets enriched in lauric, palmitic or oleic acids.
    Lagrost L; Mensink RP; Guyard-Dangremont V; Temme EH; Desrumaux C; Athias A; Hornstra G; Gambert P
    Atherosclerosis; 1999 Feb; 142(2):395-402. PubMed ID: 10030391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration: blunted response to insulin in type 2 diabetic patients.
    Riemens SC; van Tol A; Sluiter WJ; Dullaart RP
    Diabetes; 1999 Aug; 48(8):1631-7. PubMed ID: 10426383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on LCAT, PLTP, and CETP in plasma and peripheral lymph in humans.
    Kujiraoka T; Nanjee MN; Oka T; Ito M; Nagano M; Cooke CJ; Takahashi S; Olszewski WL; Wong JS; Stepanova IP; Hamilton RL; Egashira T; Hattori H; Miller NE
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1653-9. PubMed ID: 12893687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E.
    Jiang XC; Tall AR; Qin S; Lin M; Schneider M; Lalanne F; Deckert V; Desrumaux C; Athias A; Witztum JL; Lagrost L
    J Biol Chem; 2002 Aug; 277(35):31850-6. PubMed ID: 12105225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma phospholipid transfer protein. Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL.
    Föger B; Santamarina-Fojo S; Shamburek RD; Parrot CL; Talley GD; Brewer HB
    J Biol Chem; 1997 Oct; 272(43):27393-400. PubMed ID: 9341191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species. Relation to atherogenesis susceptibility.
    Guyard-Dangremont V; Desrumaux C; Gambert P; Lallemant C; Lagrost L
    Comp Biochem Physiol B Biochem Mol Biol; 1998 Jul; 120(3):517-25. PubMed ID: 9787811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndrome.
    Watts GF; Ji J; Chan DC; Ooi EM; Johnson AG; Rye KA; Barrett PH
    Clin Sci (Lond); 2006 Sep; 111(3):193-9. PubMed ID: 16700661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atherogenic, enlarged, and dysfunctional HDL in human PLTP/apoA-I double transgenic mice.
    Moerland M; Samyn H; van Gent T; Jauhiainen M; Metso J; van Haperen R; Grosveld F; van Tol A; de Crom R
    J Lipid Res; 2007 Dec; 48(12):2622-31. PubMed ID: 17761633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma phospholipid transfer protein activity and small, dense LDL in type 2 diabetes mellitus.
    Tan KC; Shiu SW; Wong Y
    Eur J Clin Invest; 2003 Apr; 33(4):301-6. PubMed ID: 12662160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma phospholipid transfer protein, cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase in end-stage renal disease (ESRD).
    Pahl MV; Ni Z; Sepassi L; Moradi H; Vaziri ND
    Nephrol Dial Transplant; 2009 Aug; 24(8):2541-6. PubMed ID: 19297356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice.
    van Haperen R; van Tol A; Vermeulen P; Jauhiainen M; van Gent T; van den Berg P; Ehnholm S; Grosveld F; van der Kamp A; de Crom R
    Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1082-8. PubMed ID: 10764677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men.
    Dullaart RP; Hoogenberg K; Dikkeschei BD; van Tol A
    Arterioscler Thromb; 1994 Oct; 14(10):1581-5. PubMed ID: 7918308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple abnormalities in the transfer of phospholipids from VLDL and LDL to HDL in non-insulin-dependent diabetes.
    Elchebly M; Pulcini T; Porokhov B; Berthezene F; Ponsin G
    Eur J Clin Invest; 1996 Mar; 26(3):216-23. PubMed ID: 8904350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.